SBC MEDICAL GROUP HOLDINGS INC (SBC)
Health Care · Healthcare Services / MSO · NASDAQ
SBC Medical Group Holdings is a technology-driven medical services organization providing AI-enabled management, marketing, and operational support to a network of aesthetic and healthcare clinics.
What SBC MEDICAL GROUP HOLDINGS INC does
SBC Medical Group Holdings is a medical services organization (MSO) that provides management support services to medical institutions, primarily in Japan. The company leverages over 26 years of accumulated management data to provide AI-enabled operational support, including call centers, marketing, and site selection, to its network of clinics across various healthcare fields such as aesthetic dermatology.
Recent developments
The company reported Q2 2026 revenue growth of 13% YoY and net income growth of 335% YoY. Management highlighted the completion of structural reforms and the integration of AI-enabled service enhancements, which are driving service fee increases and network expansion.
From SBC MEDICAL GROUP HOLDINGS INC's filing of 2026-08-13.
Themes: AI infrastructure, aesthetic medicine, medical practice management, longevity market
Fundamentals
- Price$5.34 as of 2026-10-08 close
- Market cap$549M as of 2026-07-31 (share count; price 2026-10-08)
- 1-year return+26.8% 2025-10-08 close $4.21 → 2026-10-08 close $5.34
- P/E13.44 as of 2026-10-08
- Net margin+29.4% FY2025, SEC XBRL
- Gross margin+73.3% FY2025, SEC XBRL
- ROE+20.5% FY2025, SEC XBRL
- Debt / equity0.16 as of 2026-09-02
- Revenue growth (YoY)-9.0% as of 2026-09-02
- Revenue CAGR (3y)-5.3% SEC XBRL
- Beta0.24 as of 2026-09-02
- Last reported earnings2026-08-13 SEC EDGAR Form 8-K (Item 2.02)
How SBC compares in its sector
- price-to-earnings ratiobottom 25% 185 covered Health Care peers, as of 2026-10-08
- net profit margintop 10% 430 covered Health Care peers, as of 2026-09-02
- operating margintop 10% 417 covered Health Care peers, as of 2026-09-02
- gross marginmiddle range 189 covered Health Care peers, as of 2026-09-02
- return on equitytop 25% 510 covered Health Care peers, as of 2026-09-02
- 3-year revenue CAGRbottom 25% 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)middle range 494 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
How SBC MEDICAL GROUP HOLDINGS INC looks technically
SBC MEDICAL GROUP HOLDINGS INC (SBC) is trading 37.5% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 10 trading days ago — a "golden cross", a bullish long-term signal. A strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 56, with buyers in control. Momentum is stretched — its 14-day RSI (a 0–100 momentum gauge) is 70, in overbought territory (above 70). MACD, a trend-momentum gauge, turned bullish about 4 trading days ago (its momentum flipped positive). It made a new 20-day high about 4 trading days ago. It is 3.1% below its 52-week high (its highest price of the past year).
Trend
9
| Distance from the 200-day | it is trading 37.5% above its 200-day average, the long-term trend line — a longer-term uptrend | +37.5% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $4.20 | $4.20 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $3.88 | $3.88 |
| Swing structure | each recent peak has been higher than the one before it and each dip has been shallower — the pattern chart-watchers call an uptrend, which describes where price has already been and not where it goes next | higher highs and higher lows |
| Last swing turn | its last significant turn was a swing high 17 calendar days ago — the swings before that are what the structure reading is measured on | 17 sessions |
| Wave structure | its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in the fourth leg, a pullback against that upward direction; the labelling fails if price closes below 4.33. It is the only labelling that fits, though not with textbook proportions, and it describes the swings already printed, not what comes next. | possible upward five-wave sequence, in wave 4 (atypical proportions) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 10 trading days ago — a "golden cross", a bullish long-term signal | 10 sessions |
| Above the 200-day after a dip | it recently dipped to its 200-day average (the long-term trend line) and has since climbed back above it — now about 37.5% above | +37.5% |
| Trend strength (14-day ADX) | a strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 56, with buyers in control | 55.5 |
Momentum
3
| 14-day RSI | momentum is stretched — its 14-day RSI (a 0–100 momentum gauge) is 70, in overbought territory (above 70) | 70.4 |
|---|---|---|
| Position in its 14-day range | it is trading near the top of its 14-day range ($4.66 to $5.51) — its "stochastic" reading is 80 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 80.0 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bullish about 4 trading days ago (its momentum flipped positive) | 4 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $5.51 | $5.51 |
|---|---|---|
| From the 52-week high | it is 3.1% below its 52-week high (its highest price of the past year) | -3.1% |
| Above the 52-week low | it is 92.1% above its 52-week low (its lowest price of the past year) | +92.1% |
| Below the 52-week high | it is 3.1% below its highest point of the past year | 3.1% |
| Since a 20-day breakout | it made a new 20-day high about 4 trading days ago | 4 sessions |
| Since a 55-day breakout | it made a new 55-day high about 4 trading days ago | 4 sessions |
| All-time high | its highest closing price on record is $36.52 (set on 2024-05-31) | $36.52 |
| Given back of the 52-week move | over the past year its closes ranged ($2.87 to $5.34), and it has given back essentially none of its rise from last year’s low — 0% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $3.73 to $3.81. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 0.0% |
| From the all-time high | it is 85.4% below its all-time high | -85.4% |
| Nearest price level | it is sitting right on a support level at $5.33 — a price it turned at twice since 2024-12-24, most recently on 2026-09-21. Since 2024-10-08 it has 14 such levels below the current price and 1 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -0.2% |
| All-time low | its lowest closing price on record is $2.62 (set on 2025-03-06) | $2.62 |
| Above the all-time low | it is 103.8% above its all-time low | +103.8% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are about average versus its own recent 6-month history | 48th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.2437 between its high and its low — about 4.6% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.2437 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $4.36 and $5.49 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $4.36 – $4.93 – $5.49 |
| Typical daily range (% of price) | its price moves about 4.6% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 4.6% |
| Stretch from the 200-day average | it is trading 6.0 daily ranges above its 200-day average price (37.5% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 6.0 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 1.06× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | not available for this company yet | n/a |
Candlestick patterns
1
| Since a doji | 1 session ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 1 session ago |
|---|
Price gaps
2
| Gap at the open | it opened on 2026-10-08 1.1% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | -1.1% |
|---|---|---|
| Gap filled | a 3.5% gap down opened on 2026-08-05 has been "filled" 45 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 45 sessions ago |
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 19.5 percentage points (the stock gained 20.5% while the market gained 1.0%) | +19.5% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 76.0 percentage points (the stock gained 79.8% while the market gained 3.8%) | +76.0% |
| vs market, 6 months | over the past 6 months this stock beat the market by 0.4 percentage points (the stock gained 17.9% while the market gained 17.5%) | +0.4% |
| vs market, 12 months | over the past 12 months this stock beat the market by 11.9 percentage points (the stock gained 26.8% while the market gained 15.0%) | +11.9% |
Signal agreement
2
| Bullish technical signals | 6 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, MACD momentum is positive, a strong uptrend, with buyers in control, outperforming the market over 6 months, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 6 of 9 |
|---|---|---|
| Bearish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bearish state: its RSI momentum gauge is overbought (a stretched reading), near the top of its 14-day range (overbought) — these describe past price behaviour, not a forecast | 2 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 40% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-01 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is moderate, spanning 4.3% of the share price. | +40.4% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 38% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $3.88 — a volume-weighted average of daily closes over 183 sessions, not a true tick-by-tick VWAP. | +37.6% |
|---|---|---|
| Vs the average paid since it last reported | the price is 19% above the average price paid since it last reported on 2026-08-13 (its 10-Q), so the typical buyer over that stretch is showing a gain. That average is $4.47 — a volume-weighted average of daily closes over 40 sessions, not a true tick-by-tick VWAP. | +19.4% |
Price levels it has turned at before
SBC last closed at $5.34 on 2026-10-08. Since 2024-10-08 it has turned at 14 prices below its last close and 1 above; the 3 nearest below and the nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $5.33 | Support | 0.2% below the last close | turned there twice · 2024-12-24 to 2026-09-21 |
| $5.51 | Resistance | 3.1% above the last close | turned there three times · 2025-02-04 to 2025-05-30 |
| $4.94 | Support | 7.5% below the last close | turned there three times · 2025-01-10 to 2026-02-02 |
| $4.83 | Support | 9.6% below the last close | turned there twice · 2025-02-04 to 2025-09-18 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in leg 4 of five, a pullback against that direction.
This labelling fails — stops being a possible reading at all — if it closes below $4.33.
It is the only labelling that fits these swings, though its proportions are not the textbook ones.
On past moves of this shape the leg has usually ended somewhere between $4.63 and $4.98 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
This reading has stood for 3 trading days, since 2026-10-06.
Read from daily closes as of 2026-10-08.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Recent golden cross (50-day crossed above 200-day) · Tested and reclaimed 200-day support · Overbought (14-day RSI above 70) · MACD just crossed bullish (12/26/9) · in a strong, established uptrend (ADX) | Learn: moving average · golden cross · adx · rsi · macd · breakout · fifty two week high low
Based on daily closing prices as of 2026-10-08. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingStrong Buy (1.33 mean, 1=Strong Buy…5=Strong Sell) — 4 analysts
- Mean price target$8.75 range $7.00 – $11.00; median $8.50
Analyst estimates, as of 2026-10-05. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for SBC
- Consensus EPS estimate$0.1175 next reporting period, as of 2026-10-05
- Estimate change, 30 days$0.00 (0.0%) from $0.1175, on 2026-08-31, 35-day window
- Readings revised upward0% of 7 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Internal control material weaknesses regarding financial reporting","Potential delisting risk from Nasdaq due to non-compliance with board independence requirements","Dependence on medical corporations and potential changes to management service agreements"]
Insider activity (SEC Form 4)
No open-market insider purchases or sales recorded in the last 90 days, of which we have read Form 4 filings through 2026-10-04. The 5 days since 2026-10-04 have not been checked yet.
- Last 180 days · read to 2026-10-040 buys · 2 sells ($11M) — 1 selling insider
Most recent open-market transaction: 2026-04-28. Based on Form 4 filings read through 2026-10-04; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about SBC's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
4 institutional 13F filers reported holding SBC as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 4
- Reported shares held 1,273,456
- Reported value $3,922,242
reported quarterly holdings change (2026-03-31 → 2026-06-30): 1 new, 3 increased, 0 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about SBC's institutional holders → See what each manager we track holds →
Short interest (FINRA)
SBC had 717,532 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
SBC had 0.70% of its shares outstanding sold short as of the 2026-09-15 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 4.06 days to cover at the same settlement.
- Reported short interest (shares) 717,532
- Short interest (% of shares outstanding) 0.70%
- Prior settlement (shares) 696,167
- Reported change 3.07%
- Days to cover (reported) 4.06
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- MedPeer (2355.T)
- M3, Inc. (2413.T)
- Welby Inc. (4438.T)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Frequently asked questions
What does SBC MEDICAL GROUP HOLDINGS INC (SBC) do?
SBC Medical Group Holdings is a medical services organization (MSO) that provides management support services to medical institutions, primarily in Japan. The company leverages over 26 years of accumulated management data to provide AI-enabled operational support, including call centers, marketing, and site selection, to its network of clinics across various healthcare fields such as aesthetic dermatology.
What sector is SBC MEDICAL GROUP HOLDINGS INC (SBC) in?
SBC MEDICAL GROUP HOLDINGS INC (SBC) is classified in the Health Care sector. Its industry is Healthcare Services / MSO. It trades on NASDAQ.
Who are SBC MEDICAL GROUP HOLDINGS INC's (SBC) competitors?
Notable peers of SBC MEDICAL GROUP HOLDINGS INC (SBC) include MedPeer (2355.T), M3, Inc. (2413.T) and Welby Inc. (4438.T). This peer set is informational only — not financial advice.
Is SBC MEDICAL GROUP HOLDINGS INC (SBC) overbought or oversold right now?
SBC MEDICAL GROUP HOLDINGS INC (SBC) is currently in overbought territory (its 14-day RSI is 70, above 70) (as of 2026-10-08). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on SBC come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest; prices are market data, as of 2026-09-02; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.